Forget the old VHS versus Betamax wars at the dawn of the videotape machine era, or the incompatible brains of Mac computers and PCs. Biotechnology has been grappling with an even thornier format ...

It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...

Nature uses a common framework when building organisms as different as yeast, worms, fruit flies, mice, and humans. This makes it possible for scientists to learn about how our own genes work by ...

A multicenter comparison of equipment that can analyze the expression of thousands of genes at once to create a genetic "fingerprint," suggests these different microarray technologies are more alike ...

A small German biotechnology company is literally going for the gold in the burgeoning market for DNA microarray systems. FRIZ Biochem of Munich is developing two new electrochemical DNA microarray ...

Zeptosens AG and ViaLogy Corp. today announced the results from an extensive, blinded study using Zeptosens' planar waveguide (PWG) based microarray technology and Vialogy's Quantum Resonance ...

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its ...

In order to keep pace with rapid advancements in protein microarray technology, detection systems have also been significantly improved. Important parameters critical for the success of various ...

The DNA marketplace is changing: the technology is maturing, whole human genome arrays, as well as those of model organisms, are beginning to make it onto the market, and researchers have more choices ...

Roche will purchase NimbleGen Systems for $273 million in an attempt to build its position in the genomics research market. Just last month, Roche completed a $155 million acquisition of the ...

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...

BOULDER, CO--(Marketwired - April 29, 2014) - InDevR Inc., a Boulder-based biotechnology company, and Applied Microarrays, Inc., a Tempe-based contract microarray manufacturer have partnered to ...